Impairment of Akt activity has been demonstrated under NAFLD condition, thus activated Akt (increased phosphorylation) could ameliorate hepatic steatosis and improve IR in NAFLD model (Fan et al., 2018; Jung et al., 2018). Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.